Kerry co-founded IQ Capital in 2006 and has over 20 years deep-tech venture capital experience. Originally with BDO Stoy Hayward, she joined Venture Technologies in 1998, investing in the first wave of UK deep-tech companies and has focussed on deep tech early stage technology over her five funds which invest from seed to £30m to portfolio outperformers.

Kerry specialises in GTM, Strategic Marketing, Competitive Intelligence and heads up IQ’s cybersecurity, supervisory tech, big data and neuro-tech portfolio. She sits on several boards including FNA, CyberSmart, BMLL Technologies, CybSafe, Divido, Neurovalens and Synthesized, and has conducted several exits and IPOs.

She is known as a contributor to best practice in venture capital, from ESG and a 2018 in-depth study on Investment Committee best practice and decision making across Private Equity and Venture Capital. She is the Chair of the British Private Equity and Venture Capital Association (BVCA) and a Fellow in Entrepreneurship at the University of Cambridge (Judge Business School).

Kate Bingham joined SV Health Investors in 1991 and is one of the Managing Partners managing numerous venture capital funds, including the Impact Medicine Fund, Dementia Discovery Fund (DDF), and one public fund (International Biotechnology Trust) for life sciences investing.

Kate co-leads biotech investments and activities and her investments include small-molecule, biotherapeutic and gene therapy drug discovery and development projects as well as drug discovery platforms in a broad range of clinical areas. In her 30 years at SV, Kate’s biotech investments have resulted in the launch of six drugs for the treatment of patients with inflammatory and autoimmune disease and cancer.
Prior to joining SVHI, Kate worked in business development for Vertex Pharmaceuticals, a biotechnology company in Cambridge, MA and at Monitor Company, a strategy consulting firm. Kate has a first class degree in Biochemistry from Oxford University and graduated from Harvard Business School with an MBA (Baker Scholar).

In May 2020 Kate was appointed Chair of the UK Vaccine Taskforce reporting to the Prime Minister to lead UK efforts to find and manufacture a COVID-19 vaccine on a six month engagement stepping down as Chair in December 2020. On December 8th 2020 the UK started COVID-19 vaccinations – the first Western country to do so.

Lord Browne of Madingley was born in 1948. He joined BP in 1966 as a university apprentice. He holds degrees from Cambridge University and Stanford University, California. He is a Fellow of the Royal Society, the American Academy of Arts and Sciences and the Royal Academy of Engineering. He has numerous honorary degrees, fellowships and awards.

He joined the Board of BP in 1992 and became its Group Chief Executive in 1995 until 2007. He has been the Chairman of the Advisory Board of Apax Partners LLC (2006-7), non-executive director of Intel (1997-2006), DaimlerChrysler AG (1996-2001), Goldman Sachs (1997-2007) and SmithKline Beecham (1996-1999). He was voted ‘Most Admired CEO’ by Management Today from 1999 -2002. He was knighted in 1998 and made a life peer in 2001.

He is presently a Partner of Riverstone Holdings LLC, a company which invests in renewable and conventional energy. He is Chairman of the Board of Trustees of Tate, Chairman of the Trustees of the Queen Elizabeth II Prize for Engineering and Chairman of the International Advisory Board of the Blavatnik School of Government at Oxford University. He is a member of a variety of other advisory boards.

Daniel Finkelstein is a columnist and broadcaster and former Executive Editor and Associate Editor of The Times. He is also a member of the Lords and has served as an advisor to the Conservative Party.

Danny began his career as Chair of the Young Social Democrats, a group of whom went on to join the Conservatives. After serving as director of a Westminster thinktank focusing on social policy, he became a political advisor to John Major and then William Hague and Secretary to the Shadow Cabinet. He played an early role in attempts to modernise the party alongside the likes of David Cameron and George Osborne.

Following a brief spell in data communications, Danny joined The Times, started their blog, and worked his way up to the leader columns. He's also written a highly regarded and very distinctive statistics-based football review, and regular columns for The Jewish Chronicle.

Known for taking an objective, insider's view of Westminster, Danny is a prominent commentator in the media, and a regular on Radio 4's satirical panel show The News Quiz. His talks provide a sharp and entertaining insight into the political scene examing the key policies and personalities with wry humour and genuine knowledge.

John Glen was appointed Economic Secretary to the Treasury and City Minister on 9 January 2018.

He was Parliamentary Under Secretary of State for the Department for Culture, Media and Sport from 14 June 2017 to 8 January 2018.

He was Parliamentary Private Secretary to Philip Hammond from July 2016 until June 2017.

John Glen MP was first elected to Parliament as the MP for Salisbury in 2010.

He previously worked for Eric Pickles and Sajid Javid as a Parliamentary Private Secretary.

Catherine was appointed CEO of the British Business Bank in September 2020. She has been with the British Business Bank since 2016 leading its Commercial Arm, initially as CEO of British Business Investments and taking on the additional role as CEO of British Patient Capital in October 2018.

Before joining the Bank, Catherine was Head of Private Equity for Cardano Risk Management, where she was responsible for managing a global portfolio of private capital investments on behalf of several UK pension funds. Previously she was a Partner and Managing Director of Fondinvest Capital in Paris, an investor in European private equity funds.

Prior to this Catherine was one of the founding partners of a Nordic fund-of-funds manager, Proventure, which invested in venture and growth capital funds and companies across Western Europe. Following the acquisition of Proventure in 2007, Catherine launched a consulting business advising Sovereign Wealth Funds and Institutional Investors in Asia and the US on their European private capital strategies.

Catherine graduated with First Class Honours from the London School of Economics beginning her career as an equity analyst with Venture Economics before joining CINVEN, a Private Equity firm, as an investment manager.

Philip co-founded Bridges in 2002 alongside Michele Giddens and Sir Ronald Cohen and oversees Bridges’ investment activity across all its strategies and geographies.

Phil chairs the Investment Committee and has overall responsibility for Bridges’ portfolio and exit strategy. He has personally led Bridges’ successful investments in The Gym Group, The Office Group, The Hoxton, Simply Switch and Viva Gym, among others.

As co-CEO, Philip also focuses on leading and developing Bridges’ internal team, and directing the firm’s strategic growth. He is also a regular speaker about investing for impact and the value of purpose in business.

Prior to Bridges, Philip managed two venture capital-backed businesses and a substantial pan-European business. He previously worked at Aiwa as Director and General Manager and was then appointed Managing Director of MWB Business Exchange Ltd, a serviced office provider.

Philip has a BA Honours in Economics from York University and is a qualified chartered accountant.

Joana Rocha Scaff is a Managing Director of Neuberger Berman, Head of Europe Private Equity and a member of the Co-Investment, Private Investment Portfolios and Secondary Investment Committees. Ms. Rocha Scaff has over 20 years of experience in financial markets, the majority of which in private equity investing and prior to that in investment banking. She has been with the firm since 2005. Prior to NB Private Equity, Ms. Rocha Scaff worked in the investment banking division of Lehman Brothers, and prior to that at Citigroup Global Markets and Espirito Santo Investment. She advised on corporate transactions including M&A, financial restructurings and public equity and debt offerings in the United States, Europe and Brazil. Ms. Rocha Scaff received her M.B.A. from Columbia Business School and her B.A. in Business Management and Administration from the Universidade Catolica of Lisbon. Ms. Rocha Scaff is a member of the LP Committee of the BVCA – British Private Equity Association and a member of the Limited Partner Advisory Committee of multiple European private equity funds.

Jan is a Partner at technology growth equity investor, SEP, and sits on the investment committee. With over twenty years’ investment experience, she previously held operational and commercial roles in the pharmaceutical industry.

In addition to leading SEP’s life sciences investment activities, Jan has responsibility for investor relations and sits on the responsible investment committee. Outside of SEP, Jan is a Trustee of the National Deaf Children’s Society.

Garry Wilson is the Founder and Managing Partner at Endless LLP which invests funds into UK and Irish SMEs and Mid Market Companies. Its investors have invested over £1.1billion via Endless and include 6 of the Top 10 Universities globally, some of the world’s largest Charitable and Research Foundations and Family Offices of leading global entrepreneurs. Their support has been secured through emphasising not only financial returns but also job creation and market leading ESG standards.

Endless specialises in buying business which are having a tough time. Many of its businesses have operations both in the U.K. and Ireland. Today Endless owns businesses with a combined revenue of £3billion employing over 24,000 people.